# Study of Allogenic Adipose-derived Stem Cells in Crohn's Fistula

> **NCT01440699** · PHASE1 · COMPLETED · sponsor: **Anterogen Co., Ltd.** · enrollment: 6 (actual)

## Conditions studied

- Crohn

## Interventions

- **BIOLOGICAL:** Allogenic human adipose-derived stem cells

## Key facts

- **NCT ID:** NCT01440699
- **Lead sponsor:** Anterogen Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09
- **Primary completion:** 2012-10-11
- **Final completion:** 2012-11-08
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2023-08-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01440699

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01440699, "Study of Allogenic Adipose-derived Stem Cells in Crohn's Fistula". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01440699. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*